click below
click below
Normal Size Small Size show me how
Last minute biochem
Question | Answer |
---|---|
gap between 1st 2 toes | down syndrome |
duodenal atresia | down syndrome |
increased risk of ALL | down syndrome |
decreased aFP, increased beta HCG, decreased estriol, increased inhibin A | down syndrome |
increased nuchal translucency | down syndrome (also in turner's) |
95% due to meiotic nondisjunction of homologous chromosomes | down syndrome (a/w advanced maternal age) |
4% due to robertsonian translocation | down syndrome |
1% of cases due to mosaicism | no maternal association - Down mosaicisim |
rocker bottom feet, small jaw, low set ears, clenched hands, congenital heart disease | edwards trisomy 18 |
decreased alpha fetoprotein, decreased hCG, decreased estriol, NORMAL inhibin A | trisomy 18 |
normal aFP, normal bHGC, normal estriol, normal inhibin A | patau's syndrome |
severe MR, rocker bottom feet, microphthalmia, microcephaly, cleft lip, cleft palate, holoprosencephaly, polydactyly, congenital heart disease | patau's trisomy 13 |
Kwashiokor | MEAL malnutrition Edema anemia liver (fatty) |
ubiquitous, high affinity (low Km), low capacity (low vmax), uninduced by insulin | hexokinase |
liver and beta cells of pancreas, low affinity (high Km), high capacity (high Vmax), induced by insulin | glucokinase |
feedback inhibited by glucose 6 phosphate | hexokinase |
no direct feedback inhibition | glucokinase |
phosphorylates excess glucose to sequester it in liver. Allows liver to serve as a blood glucose "buffer" | glucokinase |
where is NADPH used? | anabolic processes, respiratory burst, P450, glutathione reductase |
product of HMP shunt | NADPH |
citrate shuttle | FA synthesis sytrate = synthesis |
carnitine shuttle | FA degradation Carnage of fatty acids |
carnitine deficiency | inability to transport LCFA into the mitchondria -> toxic accumulation |
carntine deficiecny symptoms | weakness, hypotonia, hypoketotic hypolgycemia |
acyl coa dehydrogenase deficiecny | increased diacarboxylic acids, increased glucose and ketons |
1g protein or carbohydrate = ? kcal? | 4 kcal |
1g fat = ? kcal | 9 kcal |
what ketone is not detected in urine? | beta hydroxybutyrate (favored by high redox state) |
fed state | glycolysis and aerobic respiration |
fasting between meals | hepatic glycogenolysis; heaptic gluconeogenesis, adipose release of FFA (minor) |
starvation days 1-3 blood glucose levels maintain by: | hepatic glycogenolysis; adipose release of FFA; muscle and liver, which shift fuel use from glucose to FFA; hepatic gluconeogenesis from peripheral tissue lactate and alanine, and from adipose glycerol and propionyl coA |
starvation after day 3 | adipose stores (ketone bodies for brain and heart) |
2/3 of plasma cholesterol is esterified by? | lecithin cholesterol acyltransferase (LCAT) |
pancreatic lipase | degradation of dietary TG in small intestine |
LPL | degradation of TG circulating in chlomicrons and VLDL |
hepatic TG lipase | degradation of TG remaining in IDL |
HSL | degradation of TG stored in adipocytes |
LCAT | catalyzes esterification of cholesterol |
cholesterol ester transfer protein (CETP) | mediates transfer of cholesterol esters to other lipoprotein particles |
apolipoprotein E | mediates remant uptake |
apo A1 | activates LCAT |
apoC2 | lipoprotein lipase cofactor |
apo b48 | mediates chlomicron secretion |
apoB100 | binds LDL receptor |
abetalipoproteinemia | can't synthesize lipoproteins because no apob100 and b48. AR |
biopsy of someone with abetalipoproteinemia | intestinal biopsy shows accumulation within enterocytes due to inability to export absorbed lipid as chylomicrons |
abetalipoproteinemia symptoms | failure to thrive, steatorrhea, acanthocytosis, ataxia, night blindness |
LDL | transports cholesterol from liver to tissue |
HDL | transports cholesterol from peripheral to liver |
chylomicron | delivers dietary TG to peripheral tissue; dilvers cholesterol to liver in the form on chlylomicron remannts (no TG in it) |
what secretes chlymicrons? | intestinal epithelial cells |
VLDL | delivers hepatic TGs to peripheral tissu. secreted by liver |
IDL | formed in degradation of VLDL by LPL |
LDL | delivers hepatic cholesterol to peripheral tissues. taken up by target cells via receptor mediated endocytosis |
HDL | secreted from both liver and intestine |
type 1 hyperchylomicronemia | increased chylomicrons |
type 1 hyperchylomicronemia | increased TG and cholesterol |
LPL deficiency or altered apoliproprotein c2 | type 1 hyperchylomicronemia |
pancreatitis, hepatosplenomegaly, eruptive/pruitic xanthomas - no increased risk of atherosclerossi | type 1 hyperchlomicronemia |
AD; absent or decreased LDL receptors | accelerated atherosclerosis, tendon xanthomas, corneal arcus (Type 2) |
type 4 hypertriglyceridemia - | increased VLDL |
increased TG | type 4 hyperttriglyceridemia |
hepatic oveproduction of VLDL, pancreatitis | hypertriglyceridemia type 4 |